Insider Trading History of Carr Edward

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Carr Edward since 2020. This trader's CIK number is 1273351. At the time of last reporting, Carr Edward was the CHIEF ACCOUNTING OFFICER of Dianthus Therapeutics, Inc. /de/. (stock ticker symbol DNTH). Also see all insider trading activities at Dianthus Therapeutics, Inc. /de/.

Note that in the past CARR EDWARD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Dianthus Therapeutics, Inc. /de/ (DNTH) by Carr Edward

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 DNTH 0 $0 43,682 $3,617,131 43,682 $898,669

Yearly summary of insider trading at Abeona Therapeutics Inc. (ABEO) by Carr Edward

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 ABEO 0 $0 29,122 $30,607 0 $0
2020 ABEO 0 $0 6,446 $11,667 0 $0


Insider trading activities at 2 companies by Carr Edward:

1. Dianthus Therapeutics, Inc. /de/ (DNTH)

2. Abeona Therapeutics Inc. (ABEO)

Table 1. Insider trading of Dianthus Therapeutics, Inc. /de/ (DNTH) by Carr Edward

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-03-12 DNTH Sale 43,682 82.81 3,617,131
2026-03-12 DNTH Option Ex 43,682 20.57 898,669

Table 2. Insider trading of Abeona Therapeutics Inc. (ABEO) by Carr Edward

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-10-08 ABEO Sale 29,122 1.05 30,607
2020-03-19 ABEO Sale 6,446 1.81 11,667

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Carr Edward (CHIEF ACCOUNTING OFFICER of Dianthus Therapeutics, Inc. /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.